FDA Media Alert Detail

Drug Recall

FDA Drug Recall: Acthar Gel (repository corticotropin injection), 5 mL multiple-dose vial, Rx Only, Mfd. for: Mallinc...

  • U.S. Food and Drug Administration
  • September 2, 2026
  • ID: D-0803-2026

Drug Enforcement Report Details

Recall Number D-0803-2026
Recalling Firm Mallinckrodt Hospital Products Inc.
Classification Class II
Voluntary / Mandated Voluntary: Firm initiated
Distribution Pattern USA Nationwide
Status Ongoing
Product Description

Acthar Gel (repository corticotropin injection), 5 mL multiple-dose vial, Rx Only, Mfd. for: Mallinckrodt ARD LLC, Bridgewater, NJ 08807, NDC 63004-8710-1 & NDC 63004-8710-2

Reason for Recall

Presence of particulate matter: glass and stopper piece

Code Information

Lot#: NDC 63004-8710-1 - 1564-107, exp 1/31/2027 NDC 63004-8710-2 - 1564-107H, exp 1/31/2027


Content syndicated from the U.S. Food and Drug Administration (FDA) drug enforcement reports database.